Digital therapy for rehabilitation
of people with hearing disabilities...
Bell Therapeutics attracts seed investment
Bell Therapeutics, a digital therapeutics startup, has secured seed funding to develop software-based treatments aimed at reducing the rehabilitation time for cochlear implant patients, which currently extends to 1-2 years. Their approach involves leveraging advanced neuroscience and acoustics, alongside AI for personalized rehabilitation plans. The diverse team aims to innovate in the underserved cochlear implant rehabilitation market, hoping to significantly improve the quality of life for those with hearing loss.
